 | • レポートコード：MRC2Q12-19197 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、長寿とアンチエイジング薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 長寿とアンチエイジング薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 長寿とアンチエイジング薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 長寿とアンチエイジング薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの長寿とアンチエイジング薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の長寿とアンチエイジング薬の売上および2028年までの予測に焦点を当てています。 長寿とアンチエイジング薬のグローバル主要企業には、Vitality Pro、MoleQlar、Hansen Supplements、Supplement Place、Maxx Herb、Youth & Earth、Rejuvant LifeTabs、Renue By Science、Double Wood Supplements、Quicksilver Scientific、California Gold Nutrition、ProHealth Longevity、Peak Performance、Do Not Age、Nutriop、AFEGA Anti-Aging-Shop、Xi'an Angel Biotechnology Co., Ltd.、Longevity Box、Age Science、Nutravita、Aeternum、Toniiq、ProNutrition、Genex Formulas、Physicians Longevity、AlphaFit、Lovita Foods、Jarrow Formulas、Body Unionなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 長寿とアンチエイジング薬市場は、タイプとアプリケーションによって区分されます。世界の長寿とアンチエイジング薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 カルシウムAKGサプリメント、ニコチンアミドモノヌクレオチドサプリメント、その他 【アプリケーション別セグメント】 成人男性(60歳以下)、成人女性(60歳以下)、高齢者(60歳以上) 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 長寿とアンチエイジング薬製品概要 - タイプ別市場（カルシウムAKGサプリメント、ニコチンアミドモノヌクレオチドサプリメント、その他） - アプリケーション別市場（成人男性(60歳以下)、成人女性(60歳以下)、高齢者(60歳以上)） - 調査の目的 ・エグゼクティブサマリー - 世界の長寿とアンチエイジング薬販売量予測2017-2028 - 世界の長寿とアンチエイジング薬売上予測2017-2028 - 長寿とアンチエイジング薬の地域別販売量 - 長寿とアンチエイジング薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別長寿とアンチエイジング薬販売量 - 主要メーカー別長寿とアンチエイジング薬売上 - 主要メーカー別長寿とアンチエイジング薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（カルシウムAKGサプリメント、ニコチンアミドモノヌクレオチドサプリメント、その他） - 長寿とアンチエイジング薬のタイプ別販売量 - 長寿とアンチエイジング薬のタイプ別売上 - 長寿とアンチエイジング薬のタイプ別価格 ・アプリケーション別市場規模（成人男性(60歳以下)、成人女性(60歳以下)、高齢者(60歳以上)） - 長寿とアンチエイジング薬のアプリケーション別販売量 - 長寿とアンチエイジング薬のアプリケーション別売上 - 長寿とアンチエイジング薬のアプリケーション別価格 ・北米市場 - 北米の長寿とアンチエイジング薬市場規模（タイプ別、アプリケーション別） - 主要国別の長寿とアンチエイジング薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの長寿とアンチエイジング薬市場規模（タイプ別、アプリケーション別） - 主要国別の長寿とアンチエイジング薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の長寿とアンチエイジング薬市場規模（タイプ別、アプリケーション別） - 主要国別の長寿とアンチエイジング薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の長寿とアンチエイジング薬市場規模（タイプ別、アプリケーション別） - 主要国別の長寿とアンチエイジング薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの長寿とアンチエイジング薬市場規模（タイプ別、アプリケーション別） - 主要国別の長寿とアンチエイジング薬市場規模（トルコ、サウジアラビア） ・企業情報 Vitality Pro、MoleQlar、Hansen Supplements、Supplement Place、Maxx Herb、Youth & Earth、Rejuvant LifeTabs、Renue By Science、Double Wood Supplements、Quicksilver Scientific、California Gold Nutrition、ProHealth Longevity、Peak Performance、Do Not Age、Nutriop、AFEGA Anti-Aging-Shop、Xi'an Angel Biotechnology Co., Ltd.、Longevity Box、Age Science、Nutravita、Aeternum、Toniiq、ProNutrition、Genex Formulas、Physicians Longevity、AlphaFit、Lovita Foods、Jarrow Formulas、Body Union ・産業チェーン及び販売チャネル分析 - 長寿とアンチエイジング薬の産業チェーン分析 - 長寿とアンチエイジング薬の原材料 - 長寿とアンチエイジング薬の生産プロセス - 長寿とアンチエイジング薬の販売及びマーケティング - 長寿とアンチエイジング薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 長寿とアンチエイジング薬の産業動向 - 長寿とアンチエイジング薬のマーケットドライバー - 長寿とアンチエイジング薬の課題 - 長寿とアンチエイジング薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Longevity and Anti-Aging Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Longevity and Anti-Aging Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Longevity and Anti-Aging Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Longevity and Anti-Aging Drugs include Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place, Maxx Herb, Youth & Earth, Rejuvant LifeTabs, Renue By Science and Double Wood Supplements, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Longevity and Anti-Aging Drugs manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Longevity and Anti-Aging Drugs market. Further, it explains the major drivers and regional dynamics of the global Longevity and Anti-Aging Drugs market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Vitality Pro
MoleQlar
Hansen Supplements
Supplement Place
Maxx Herb
Youth & Earth
Rejuvant LifeTabs
Renue By Science
Double Wood Supplements
Quicksilver Scientific
California Gold Nutrition
ProHealth Longevity
Peak Performance
Do Not Age
Nutriop
AFEGA Anti-Aging-Shop
Xi’an Angel Biotechnology Co., Ltd.
Longevity Box
Age Science
Nutravita
Aeternum
Toniiq
ProNutrition
Genex Formulas
Physicians Longevity
AlphaFit
Lovita Foods
Jarrow Formulas
Body Union
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Longevity and Anti-Aging Drugs Segment by Type
Calcium AKG Supplement
Nicotinamide Mononucleotide Supplement
Others
Longevity and Anti-Aging Drugs Segment by Application
Adult Male (Under 60 Years Old)
Adult Female (Under 60 Years Old)
Elderly (Above 60 Years Old)
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Longevity and Anti-Aging Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Longevity and Anti-Aging Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Longevity and Anti-Aging Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Longevity and Anti-Aging Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Longevity and Anti-Aging Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Longevity and Anti-Aging Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Longevity and Anti-Aging Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place, Maxx Herb, Youth & Earth, Rejuvant LifeTabs, Renue By Science and Double Wood Supplements, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Longevity and Anti-Aging Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Longevity and Anti-Aging Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Longevity and Anti-Aging Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Longevity and Anti-Aging Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Longevity and Anti-Aging Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Calcium AKG Supplement
1.2.3 Nicotinamide Mononucleotide Supplement
1.2.4 Others
1.3 Market by Application
1.3.1 Global Longevity and Anti-Aging Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adult Male (Under 60 Years Old)
1.3.3 Adult Female (Under 60 Years Old)
1.3.4 Elderly (Above 60 Years Old)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Longevity and Anti-Aging Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Longevity and Anti-Aging Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Longevity and Anti-Aging Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Longevity and Anti-Aging Drugs Sales by Region
2.4.1 Global Longevity and Anti-Aging Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Longevity and Anti-Aging Drugs by Region (2023-2028)
2.5 Global Longevity and Anti-Aging Drugs Revenue by Region
2.5.1 Global Longevity and Anti-Aging Drugs Revenue by Region (2017-2022)
2.5.2 Global Longevity and Anti-Aging Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Longevity and Anti-Aging Drugs Sales by Manufacturers
3.1.1 Global Top Longevity and Anti-Aging Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Longevity and Anti-Aging Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Longevity and Anti-Aging Drugs in 2021
3.2 Global Longevity and Anti-Aging Drugs Revenue by Manufacturers
3.2.1 Global Longevity and Anti-Aging Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Longevity and Anti-Aging Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Longevity and Anti-Aging Drugs Revenue in 2021
3.3 Global Longevity and Anti-Aging Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Longevity and Anti-Aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Longevity and Anti-Aging Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Longevity and Anti-Aging Drugs Sales by Type
4.1.1 Global Longevity and Anti-Aging Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Longevity and Anti-Aging Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2028)
4.2 Global Longevity and Anti-Aging Drugs Revenue by Type
4.2.1 Global Longevity and Anti-Aging Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Longevity and Anti-Aging Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Longevity and Anti-Aging Drugs Price by Type
4.3.1 Global Longevity and Anti-Aging Drugs Price by Type (2017-2022)
4.3.2 Global Longevity and Anti-Aging Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Longevity and Anti-Aging Drugs Sales by Application
5.1.1 Global Longevity and Anti-Aging Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Longevity and Anti-Aging Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2028)
5.2 Global Longevity and Anti-Aging Drugs Revenue by Application
5.2.1 Global Longevity and Anti-Aging Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Longevity and Anti-Aging Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Longevity and Anti-Aging Drugs Price by Application
5.3.1 Global Longevity and Anti-Aging Drugs Price by Application (2017-2022)
5.3.2 Global Longevity and Anti-Aging Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Longevity and Anti-Aging Drugs Market Size by Type
6.1.1 North America Longevity and Anti-Aging Drugs Sales by Type (2017-2028)
6.1.2 North America Longevity and Anti-Aging Drugs Revenue by Type (2017-2028)
6.2 North America Longevity and Anti-Aging Drugs Market Size by Application
6.2.1 North America Longevity and Anti-Aging Drugs Sales by Application (2017-2028)
6.2.2 North America Longevity and Anti-Aging Drugs Revenue by Application (2017-2028)
6.3 North America Longevity and Anti-Aging Drugs Market Size by Country
6.3.1 North America Longevity and Anti-Aging Drugs Sales by Country (2017-2028)
6.3.2 North America Longevity and Anti-Aging Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Longevity and Anti-Aging Drugs Market Size by Type
7.1.1 Europe Longevity and Anti-Aging Drugs Sales by Type (2017-2028)
7.1.2 Europe Longevity and Anti-Aging Drugs Revenue by Type (2017-2028)
7.2 Europe Longevity and Anti-Aging Drugs Market Size by Application
7.2.1 Europe Longevity and Anti-Aging Drugs Sales by Application (2017-2028)
7.2.2 Europe Longevity and Anti-Aging Drugs Revenue by Application (2017-2028)
7.3 Europe Longevity and Anti-Aging Drugs Market Size by Country
7.3.1 Europe Longevity and Anti-Aging Drugs Sales by Country (2017-2028)
7.3.2 Europe Longevity and Anti-Aging Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Longevity and Anti-Aging Drugs Market Size by Type
8.1.1 Asia Pacific Longevity and Anti-Aging Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Longevity and Anti-Aging Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Longevity and Anti-Aging Drugs Market Size by Application
8.2.1 Asia Pacific Longevity and Anti-Aging Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Longevity and Anti-Aging Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Longevity and Anti-Aging Drugs Market Size by Region
8.3.1 Asia Pacific Longevity and Anti-Aging Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Longevity and Anti-Aging Drugs Market Size by Type
9.1.1 Latin America Longevity and Anti-Aging Drugs Sales by Type (2017-2028)
9.1.2 Latin America Longevity and Anti-Aging Drugs Revenue by Type (2017-2028)
9.2 Latin America Longevity and Anti-Aging Drugs Market Size by Application
9.2.1 Latin America Longevity and Anti-Aging Drugs Sales by Application (2017-2028)
9.2.2 Latin America Longevity and Anti-Aging Drugs Revenue by Application (2017-2028)
9.3 Latin America Longevity and Anti-Aging Drugs Market Size by Country
9.3.1 Latin America Longevity and Anti-Aging Drugs Sales by Country (2017-2028)
9.3.2 Latin America Longevity and Anti-Aging Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Longevity and Anti-Aging Drugs Market Size by Type
10.1.1 Middle East and Africa Longevity and Anti-Aging Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Longevity and Anti-Aging Drugs Market Size by Application
10.2.1 Middle East and Africa Longevity and Anti-Aging Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Longevity and Anti-Aging Drugs Market Size by Country
10.3.1 Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Vitality Pro
11.1.1 Vitality Pro Corporation Information
11.1.2 Vitality Pro Overview
11.1.3 Vitality Pro Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Vitality Pro Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Vitality Pro Recent Developments
11.2 MoleQlar
11.2.1 MoleQlar Corporation Information
11.2.2 MoleQlar Overview
11.2.3 MoleQlar Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 MoleQlar Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MoleQlar Recent Developments
11.3 Hansen Supplements
11.3.1 Hansen Supplements Corporation Information
11.3.2 Hansen Supplements Overview
11.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hansen Supplements Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hansen Supplements Recent Developments
11.4 Supplement Place
11.4.1 Supplement Place Corporation Information
11.4.2 Supplement Place Overview
11.4.3 Supplement Place Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Supplement Place Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Supplement Place Recent Developments
11.5 Maxx Herb
11.5.1 Maxx Herb Corporation Information
11.5.2 Maxx Herb Overview
11.5.3 Maxx Herb Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Maxx Herb Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Maxx Herb Recent Developments
11.6 Youth & Earth
11.6.1 Youth & Earth Corporation Information
11.6.2 Youth & Earth Overview
11.6.3 Youth & Earth Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Youth & Earth Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Youth & Earth Recent Developments
11.7 Rejuvant LifeTabs
11.7.1 Rejuvant LifeTabs Corporation Information
11.7.2 Rejuvant LifeTabs Overview
11.7.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Rejuvant LifeTabs Recent Developments
11.8 Renue By Science
11.8.1 Renue By Science Corporation Information
11.8.2 Renue By Science Overview
11.8.3 Renue By Science Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Renue By Science Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Renue By Science Recent Developments
11.9 Double Wood Supplements
11.9.1 Double Wood Supplements Corporation Information
11.9.2 Double Wood Supplements Overview
11.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Double Wood Supplements Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Double Wood Supplements Recent Developments
11.10 Quicksilver Scientific
11.10.1 Quicksilver Scientific Corporation Information
11.10.2 Quicksilver Scientific Overview
11.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quicksilver Scientific Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quicksilver Scientific Recent Developments
11.11 California Gold Nutrition
11.11.1 California Gold Nutrition Corporation Information
11.11.2 California Gold Nutrition Overview
11.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 California Gold Nutrition Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 California Gold Nutrition Recent Developments
11.12 ProHealth Longevity
11.12.1 ProHealth Longevity Corporation Information
11.12.2 ProHealth Longevity Overview
11.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ProHealth Longevity Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ProHealth Longevity Recent Developments
11.13 Peak Performance
11.13.1 Peak Performance Corporation Information
11.13.2 Peak Performance Overview
11.13.3 Peak Performance Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Peak Performance Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Peak Performance Recent Developments
11.14 Do Not Age
11.14.1 Do Not Age Corporation Information
11.14.2 Do Not Age Overview
11.14.3 Do Not Age Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Do Not Age Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Do Not Age Recent Developments
11.15 Nutriop
11.15.1 Nutriop Corporation Information
11.15.2 Nutriop Overview
11.15.3 Nutriop Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Nutriop Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nutriop Recent Developments
11.16 AFEGA Anti-Aging-Shop
11.16.1 AFEGA Anti-Aging-Shop Corporation Information
11.16.2 AFEGA Anti-Aging-Shop Overview
11.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 AFEGA Anti-Aging-Shop Recent Developments
11.17 Xi’an Angel Biotechnology Co., Ltd.
11.17.1 Xi’an Angel Biotechnology Co., Ltd. Corporation Information
11.17.2 Xi’an Angel Biotechnology Co., Ltd. Overview
11.17.3 Xi’an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Xi’an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Xi’an Angel Biotechnology Co., Ltd. Recent Developments
11.18 Longevity Box
11.18.1 Longevity Box Corporation Information
11.18.2 Longevity Box Overview
11.18.3 Longevity Box Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Longevity Box Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Longevity Box Recent Developments
11.19 Age Science
11.19.1 Age Science Corporation Information
11.19.2 Age Science Overview
11.19.3 Age Science Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Age Science Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Age Science Recent Developments
11.20 Nutravita
11.20.1 Nutravita Corporation Information
11.20.2 Nutravita Overview
11.20.3 Nutravita Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Nutravita Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Nutravita Recent Developments
11.21 Aeternum
11.21.1 Aeternum Corporation Information
11.21.2 Aeternum Overview
11.21.3 Aeternum Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Aeternum Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Aeternum Recent Developments
11.22 Toniiq
11.22.1 Toniiq Corporation Information
11.22.2 Toniiq Overview
11.22.3 Toniiq Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Toniiq Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Toniiq Recent Developments
11.23 ProNutrition
11.23.1 ProNutrition Corporation Information
11.23.2 ProNutrition Overview
11.23.3 ProNutrition Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 ProNutrition Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 ProNutrition Recent Developments
11.24 Genex Formulas
11.24.1 Genex Formulas Corporation Information
11.24.2 Genex Formulas Overview
11.24.3 Genex Formulas Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Genex Formulas Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Genex Formulas Recent Developments
11.25 Physicians Longevity
11.25.1 Physicians Longevity Corporation Information
11.25.2 Physicians Longevity Overview
11.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Physicians Longevity Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Physicians Longevity Recent Developments
11.26 AlphaFit
11.26.1 AlphaFit Corporation Information
11.26.2 AlphaFit Overview
11.26.3 AlphaFit Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 AlphaFit Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 AlphaFit Recent Developments
11.27 Lovita Foods
11.27.1 Lovita Foods Corporation Information
11.27.2 Lovita Foods Overview
11.27.3 Lovita Foods Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Lovita Foods Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Lovita Foods Recent Developments
11.28 Jarrow Formulas
11.28.1 Jarrow Formulas Corporation Information
11.28.2 Jarrow Formulas Overview
11.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.28.4 Jarrow Formulas Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Jarrow Formulas Recent Developments
11.29 Body Union
11.29.1 Body Union Corporation Information
11.29.2 Body Union Overview
11.29.3 Body Union Longevity and Anti-Aging Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.29.4 Body Union Longevity and Anti-Aging Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Body Union Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Longevity and Anti-Aging Drugs Industry Chain Analysis
12.2 Longevity and Anti-Aging Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Longevity and Anti-Aging Drugs Production Mode & Process
12.4 Longevity and Anti-Aging Drugs Sales and Marketing
12.4.1 Longevity and Anti-Aging Drugs Sales Channels
12.4.2 Longevity and Anti-Aging Drugs Distributors
12.5 Longevity and Anti-Aging Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Longevity and Anti-Aging Drugs Industry Trends
13.2 Longevity and Anti-Aging Drugs Market Drivers
13.3 Longevity and Anti-Aging Drugs Market Challenges
13.4 Longevity and Anti-Aging Drugs Market Restraints
14 Key Findings in The Global Longevity and Anti-Aging Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer